McKay Andrew, Fradette Katherine, Lipschitz Jeremy
Department of Surgery, Health Sciences Centre, University of Manitoba, Winnipeg, MB, Canada R3A 1R9.
HPB Surg. 2009;2009:346863. doi: 10.1155/2009/346863. Epub 2010 Feb 1.
Recently some have called for randomized controlled trials comparing RFA to hepatic resection, particularly for patients with only a few small metastases. The objectives were to compare local recurrence and survival following RFA and hepatic resection for colorectal liver metastases. This was a retrospective review of open RFA and hepatic resection for colorectal liver metastases between January 1998 and May 2007. All patients who had RFA were considered to have unresectable disease. 58 patients had hepatic resection and 43 had RFA. A 5-year survival after resection was 43% compared to 23% after RFA. For patients with solitary lesions, a 5-year survival was 48% after resection and 15% after RFA. Sixty percent of patients suffered local recurrences after RFA compared to 7% after hepatic resection. RFA is inferior to resection. The results observed in this study support the consensus that RFA cannot be considered an equivalent procedure to hepatic resection.
最近,一些人呼吁开展随机对照试验,比较射频消融(RFA)与肝切除术,特别是对于仅有少数小转移灶的患者。目的是比较RFA和肝切除术后结直肠癌肝转移患者的局部复发情况和生存率。这是一项对1998年1月至2007年5月间接受开放性RFA和肝切除术治疗结直肠癌肝转移患者的回顾性研究。所有接受RFA治疗的患者均被视为患有不可切除的疾病。58例患者接受了肝切除术,43例接受了RFA治疗。切除术后5年生存率为43%,而RFA术后为23%。对于孤立性病变患者,切除术后5年生存率为48%,RFA术后为15%。60%的患者在RFA术后出现局部复发,而肝切除术后这一比例为7%。RFA不如切除术。本研究观察到的结果支持以下共识:RFA不能被视为与肝切除术等效的手术。